[
  {
    "ts": null,
    "headline": "Mercy BioAnalytics Appoints Dr. Prasanth Reddy as Chief Medical Officer",
    "summary": "Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced the appointment of Prasanth Reddy, M.D. MPH, FACP, as its Chief Medical Officer. Dr. Reddy brings critical experience in precision oncology, product development, and patient access, and will play a pivotal role in advancing Mercy's mission to save lives and relieve suffering through early cancer detection.",
    "url": "https://finnhub.io/api/news?id=26e91f7cc9b54b6d12df1c28ec121212ed7481c5789f972a9661f8204b52212c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751982120,
      "headline": "Mercy BioAnalytics Appoints Dr. Prasanth Reddy as Chief Medical Officer",
      "id": 135807032,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced the appointment of Prasanth Reddy, M.D. MPH, FACP, as its Chief Medical Officer. Dr. Reddy brings critical experience in precision oncology, product development, and patient access, and will play a pivotal role in advancing Mercy's mission to save lives and relieve suffering through early cancer detection.",
      "url": "https://finnhub.io/api/news?id=26e91f7cc9b54b6d12df1c28ec121212ed7481c5789f972a9661f8204b52212c"
    }
  },
  {
    "ts": null,
    "headline": "Privia Health Announces Appointment of Lance V. Berberian to its Board of Directors",
    "summary": "Berberian brings significant technology leadership and cybersecurity expertiseARLINGTON, Va., July 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Lance V. Berberian to its Board of Directors, effective July 15, 2025. He has also been named a member of the Audit Committee of the Board. Following the appointment of Mr. Berberian, the Board will comprise 10 directors. “We are excited to welcome Lance to our Board of Directors,” said David King, Ch",
    "url": "https://finnhub.io/api/news?id=17a151dbc35b9960b93ab7a6636125653db72fa14550ee6d2918520249286dce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751979600,
      "headline": "Privia Health Announces Appointment of Lance V. Berberian to its Board of Directors",
      "id": 135807033,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Berberian brings significant technology leadership and cybersecurity expertiseARLINGTON, Va., July 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Lance V. Berberian to its Board of Directors, effective July 15, 2025. He has also been named a member of the Audit Committee of the Board. Following the appointment of Mr. Berberian, the Board will comprise 10 directors. “We are excited to welcome Lance to our Board of Directors,” said David King, Ch",
      "url": "https://finnhub.io/api/news?id=17a151dbc35b9960b93ab7a6636125653db72fa14550ee6d2918520249286dce"
    }
  }
]